IMA FY 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+237.0% YoY

Gross Profit

-$16M-52.0% margin

Operating Income

-$34M-110.2% margin

Net Income

-$34M-110.1% margin

EPS (Diluted)

$-0.95

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$62M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$248M

Total Liabilities

$40M

Stockholders' Equity

$208M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$9M	+237.0%
Gross Profit	-$16M	-$36M	+54.8%
Operating Income	-$34M	-$45M	+23.3%
Net Income	-$34M	-$44M	+22.9%